CLINICAL EFFICACY AND SAFETY PROFILE OF SODIUM CROMOGLYCATE 4% (LECROLIN) IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
DOI:
https://doi.org/10.5281/zenodo.23204637Keywords:
allergic conjunctivitis, seasonal allergic conjunctivitis, chronic allergic conjunctivitis, sodium cromoglycate, cromolyn sodium, Lecrolin, mast-cell stabilizer, topical ophthalmic therapy, ocular allergyAbstract
Allergic conjunctivitis is one of the most common ocular allergic disorders and represents a significant medical and quality-of-life burden. Increasing rates of sensitization to environmental allergens necessitate effective and well-tolerated topical therapies with pathogenetically targeted mechanisms of action. Sodium cromoglycate, a mast-cell stabilizing agent, has been used in the management of allergic ocular diseases for several decades.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Gulrukh Farkhatova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
